维普中文期刊产品整合服务
13篇 您的检索式:作者名="Rybak M E"
    题名 作者 年代 出处 被引量
1Tigecycline: first of a new class of antimicrobial agents显示文摘Rose W E Rybak M J 2006Pharmacotherapy2006,26,8:1
2Histologic changes induced in skin by extravasation of doxorubicin ( adriamycin ) 显示文摘Bhawan J Petry J Rybak M E 1989J Cutan Pathol1989,16,3:1
3Enhancement of Vincristine Cytotoxicity in Drug-Resistant Cells by Simultaneous Treatment With Onconase,an Antitumor Ribonuclease显示文摘Rybak S M Pearson J W Fogler W E 1996J Natl Cancer Inst1996,88,11:1
4Treatment of ebola virus disease 显示文摘Kilgore P E Grabenstein J D Salim A M Rybak M 2015Pharmacotherapy2015,,:1
5Correction of anxiety depressive disorders with tianeptine in patients with heart failure in early period after myocardial infarction显示文摘STATSENKO M E RYBAK V A GOVORUKHA O A 2005ICardiologiia2005,45,12:1
6Ceftaroline:a new cephalosporin with activity against resistant gram-positive pathogens 显示文摘STEED M E RYBAK M J 2010Pharmacotherapy2010,30,4:1
7Direct determination of metals in soils and sediments by induction heating - electrothermal vaporization ( IH - ETV ) inductively coupled plasma - optical emission spectrometry ( ICP - AES) 显示文摘Rybak M E Salin E D 2001Appl Spectrosc2001,55,7:1
8Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations显示文摘Rose W E Leonard S N Rybak M J 2008Antimicrob Agents Chemother2008,52,9:1
9In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin - dalfopristin against staphylococci and enterococci, including vancomycin - in- termediate and - resistant strains 显示文摘Rybak M J Hershberger E Moldovan T 2000Antimicrob Agents Che- mother2000,44,4:1
10Protec- tion by low-dose kanamycin against noise-induced hearing loss in mice: Dependence on dosing regimen and genetic back- ground显示文摘Ohlemiller K K Rybak Rice M E Rosen A D 2011Hear Res2011,280,112:1
11In vitro activities of daptomycin,vancomycin,linezolid,and quinupristin-dalfopristin against Staphylococci and Enterococci,including vancomycin-intermediate and resistant strains显示文摘RYBAK M J HERSHBERGER E MOLDOVAN T 2000Antimicrob Agents Chemother2000,44,4:1
12Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function 显示文摘Rose W E Rybak M J Tsuji B T 2007Antimierob Chemother2007,59,6:1
13Current and prospective treatments for multidrug-resistant gram-positive infections显示文摘Jeffrey M Rybak Katie E Barber Michael J Rybak 2013Expert Opinion on Pharmacotherapy2013,,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费